Remove Clinical Development Remove Gene Editing Remove Gene Sequencing Remove Licensing
article thumbnail

Touchlight boosts DNA manufacturing capacity with latest expansion

Pharmaceutical Technology

As per the company, dbDNA is suitable for rapid, scalable manufacture of GMP DNA and can incorporate gene sequences of sizes ranging from 500bp to 20kb, which are typically unstable as pDNA. Last year, Odimma Therapeutics began utilising Touchlight’s platform to develop an immunotherapy cancer treatment.

DNA 130